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 Current legal status of these herbs 
 Long term care:                  Convallaria majalis 
 Acute care:                         Chelidonium majus 
 Dosage:                              Lobelia inflata 
 Quality assurance:             Hyoscyamus niger 
 Practitioners:           Gelsemium sempervirens 
 
“Schedule III”:  
Part 3 of SI 1977/2130 
  Substances which may be prescribed by 
herbal practitioners 'after being requested by 
or on behalf of that person and in that 
person's presence to use his own judgement 
as to the treatment required.’ 
 Medicines [Retail Sale or Supply of Herbal 
Remedies] Order 1977 (SI 1977/2130):  
 will form Schedule 20, Human Medicines 
Regulations 2012 (MHRA, 2011) 
DRAFT: The Human Medicines 
Regulations 2012 
3  (1) Subject to paragraph (8), these Regulations shall not 
apply in circumstances where any of the following 
paragraphs of this regulation applies............. 
 (4) This paragraph applies where a herbal medicinal 
product is manufactured or assembled by a person (“A”) 
if— 
 (a) the manufacture or assembly takes place on 
premises occupied by A and from which A can exclude 
the public; 
 (b) the product is for administration to a person (“B”) and 
A has been requested by or on behalf of B, and in B’s 
presence, to use A’s judgment as to the treatment 
required;  
 
Long term care:  
Convallaria  
majalis 
 
150mg maximum dose 
450mg maximum dose/day 
 
= 2.25 ml daily of 1:5 
Tincture 
or 15ml per week  
(assuming 5ml tds) 
 
Man, age 83, now 90, atrial 
fibrillation  
Herb Tr. Conc. ml 
Flor. Crataegus monogyna 
 
1:3      45% 20 
Rad. Salvia miltiorrhiza (own, decocted) 
 
 
1:4      25% 20 
Fol. Convallaria majalis 1:5      45% 10 
Fol. Hypericum perforatum (fresh) 1:3      60% 
(varies) 
30 
Cort. Cinnamomum zeylanicum 1:3      45% 20 
Other herbs: Ginkgo biloba, Aesculus hippocastanum, 
Zingiber officinalis, Eleutherococcus senticoccus 
100 
Dose: 5ml bd. (takes somewhat less) 
Acute care: Chelidonium majus 
 
Man, age 39, attacks of pain for up to 8 hours at 
night, for last 8 weeks, “too busy to have op”, 
scan, “inflamed and shrivelled gall bladder” 
Herb Tr. ml. 
Fol/flor. Chelidonium majus (own, fresh, 1:3 30% approx.) 15 
Rad. Taraxacum officinale 15 
Fol. Galium aparine 10 
Fol. Verbena officinalis 15 
Rad. Echinacea purpurea (decocted) 10 
Rad. Astragalus membranaceus (decocted) 15 
Rad. Angelica archangelica (fresh) 15 
Dose: 5ml tds 95! 
Also, Ulmus fulva powder, oats, and to eat sitting down! Mitte 190! 
 
 
 
 
Risk/benefit? 
 “highly praised in western phytotherapy and traditional 
Chinese medicine” (Gilca et al., 2010) 
 Main indications: “cholecystitis”, gall stones (BHP) but 
used for liver function in the wider sense 
 “Schedule III” dose very high 
 BHP (1983) recommends 2-4 mL tds, Tr. 1:10 
 
 22 spontaneous reports of hepatotoxicity (highly 
probable 2, probable 6, possible 10) (Teschke et al., 
2011)  
    Commission E: “cramp-like disorders of the biliary and 
gastrointestinal tract” 
 
Dosage: Lobelia inflata, as 
expectorant  
 
 
 
 
 
 
 
 
www.ncwildflower.org 
Bronchial muscles 
relax; cough 
productive 
“spasmodic asthma 
with secondary 
bronchitis” 
(BHP, 1983) 
Maximum dose: 200 mg 
Maximum daily: 600 mg 
Tincture 1:5:   3 ml daily 
 
 
 
 
Lobelia inflata, as expectorant  
 Only use briefly where the person has low 
energy (Priest, Priest, 1982) 
 So, remember external usage (Church, 1995) 
 
 Cook (1869) argues a 1:10 tincture in vinegar is 
useful expectorant (less emetic),  
    5-10 drops per hour in demulcent tea 
 And I make this preparation for my dispensary  
 I took 5mL, 1:10 at night, 6 nights (500mg) 
 
Traditional expectorant formulations: 
Acid tincture of Lobelia inflata 
Skelton (1852) 1:8 (approx) 
50g seed, 10g leaf, 1 tsp cayenne in 500 mL vinegar 
(Imperial teaspoon was 3.5 mL (Tobyn et al, 2010)  
Dose in asthma: 2-3 tsp, night (7-10mL) = 1200  mg 
Fox (1909) 1:5                   50g seed, 50g herb 
Macerate, 500mL vinegar, 7 days. Shake daily. 
 Dose: 15 drops tds in tea of Marrubium vulgare  
 (for Marrubium, see de Vos, 2010). 
 Estimating 20 drops = 1 mL, this is 16ml/week.  
 Dispense mL not drops!  
 Label: Take three 5mL doses a day. Do not exceed 
dose.   
 
 
 
Quality: 
Hyoscyamus niger, Turkey 
Practitioners:  
Gelsemium sempervirens, Italy 
 
Survey of Members of NIMH: 
1998 (Denham, 1999) 
Which conditions would you find hard to treat without 
Gelsemium? 
 migraine; recurrent headache 
 severe pain due to osteoarthritis, injury, multiple 
sclerosis 
 atrial fibrillation  
 Meniere’s Disease; insomnia,  
 period pain 
 Neuralgia; post-herpetic neuralgia; trapped nerve 
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